Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells

Oncology Reports

Volumn 15, Issue 3, 2006, Pages 571-576

  Niiya, Masami ^a   Niiya, Kenji ^b   Shibakura, Misako ^a   Asaumi, Noboru ^a   Yoshida, Chikamasa ^a   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Kasaoka Hospital   (Japan)

Author keywords

Amurubicin; Amurubicinol; Eotaxin 3; Interleukin 8; Monocyte chemoattractant protein 1; Small cell lung carcinoma cells; Urokinase type plasminogen activator

Indexed keywords

AMRUBICIN; AMRUBICINOL; ANTHRACYCLINE; BETA CHEMOKINE; CCL2 PROTEIN, HUMAN; CCL26 PROTEIN, HUMAN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; UROKINASE;

ANIMAL; ARTICLE; CELL MOTION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; NORTHERN BLOTTING; PATHOLOGY; PHYSIOLOGY; RABBIT; SMALL CELL CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR CELL LINE;

ANIMALS; ANTHRACYCLINES; BLOTTING, NORTHERN; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL2; CHEMOKINES, CC; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-8; LUNG NEOPLASMS; RABBITS; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

EID: 33645731833     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.3.571     Document Type: Article

References (34)

1. Muller I, Niethammer D and Bruchelt G: Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). Int J Mol Med 1: 491-494, 1998.
2. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr and Miller TP: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328: 1002-1006, 1993. (Pubitemid 23095683)
3. Zochbauer-Muller S, Pirker R and Huber H: Treatment of small cell lung cancer patients. Ann Oncol 10 (Suppl 6): 83-91, 1999.
4. Kiguchi T, Niiya K, Shibakura M, Miyazono T, Shinagawa K, Ishimaru F, Kiura K, Ikeda K, Nakata Y and Harada M: Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells. Int J Cancer 93: 792-797, 2001. (Pubitemid 32756747)
5. Shibakura M, Niiya K, Kiguchi T, Kitajima I, Niiya M, Asaumi N, Huh NH, Nakata Y, Harada M and Tanimoto M: Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells. Int J Cancer 103: 380-386, 2003. (Pubitemid 36076431)
6. Niiya M, Niiya K, Kiguchi T, Shibakura M, Asaumi N, Shinagawa K, Ishimaru F, Kiura K, Ikeda K, Ueoka H, et al: Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells. Cancer Chemother Pharmacol 52: 391-398, 2003. (Pubitemid 37363612)
7. Noguchi T, Ichii S, Morisada S, Yamaoka T and Yanagi Y: Tumor-selective distribution of an active metabolite of the 9-aminoanthracycline amrubicin. Jpn J Cancer Res 89: 1061-1066, 1998. (Pubitemid 28544783)
8. Yamauchi S, Kudoh S, Kimura T, Hirata K and Yoshikawa J: Additive effects of amrubicin with cisplatin on human lung cancer cell lines. Osaka City Med J 48: 69-76, 2002.
9. Morisada S, Yanagi Y, Noguchi T, Kashiwazaki Y and Fukui M: Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts. Jpn J Cancer Res 80: 69-76, 1989. (Pubitemid 20027201)
10. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ and Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84: 9233-9237, 1987.
11. Baggiolini M, Dewald B and Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55: 97-179, 1994.
12. Furutani Y, Nomura H, Notake M, Oyamada Y, Fukui T, Yamada M, Larsen CG, Oppenheim JJ and Matsushima K: Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun 159: 249-255, 1989. (Pubitemid 19087637)
13. Montovani A, Sozzani S, Proost P and van Damme J: The monocyte chemoattractant protein family. In Chemoattractant Ligands and their Receptors: Pharmacology and Toxicology: Basic and Clinical Aspects. Horuk R (ed). CRC Press, Boca Raton, FL, pp169-192, 1996.
14. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
15. Niiya K, Nsimba M, Hayashi T and Sakuragawa N: Downregulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors. Thromb Res 65: 311-321, 1992.
16. Granelli-Piperno A and Reich E: A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 148: 223-234, 1978. (Pubitemid 8376490)
17. Sambrook J, Fritsh EF and Maniatis T: Molecular Cloning, A Laboratory Manual. 2nd edition, Cold Spring Harbor Laboratory, pp7-39, 1989.
18. Terada N, Hamano N, Nomura T, Numata T, Hirai K, Nakajima T, Yamada H, Yoshie O, Ikeda-Ito T and Konno A: Interleukin-13 and tumour necrosis factor-alpha synergistically induce eotaxin production in human nasal fibroblasts. Clin Exp Allergy 30: 348-355, 2000. (Pubitemid 30167250)
19. Dulkys Y, Schramm G, Kimmig D, Knoss S, Weyergraf A, Kapp A and Elsner J: Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. J Invest Dermatol 116: 498-505, 2001. (Pubitemid 32299836)
20. Hoeck J and Woisetschlager M: Activation of eotaxin-3/CCL126 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 167: 3216-3222, 2001. (Pubitemid 32852561)
21. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K and Sakiyama S: Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 47: 5616-5619, 1987. (Pubitemid 18046754)
22. Niiya M, Niiya K, Shibakura M, Asaumi N, Yoshida C, Shinagawa K, Teshima T, Ishimaru F, Ikeda K and Tanimoto M: Involvement of ERK1/2 and p38 MAP kinase in doxorubicininduced uPA expression in human RC-K8 lymphoma and NCIH69 small cell lung carcinoma cells. Oncology 67: 310-319, 2004. (Pubitemid 39551716)
23. Lampinen M, Carlson M, Hakansson LD and Venge P: Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59: 793-805, 2004. (Pubitemid 39005818)
24. Kitaura M, Suzuki N, Imai T, Takagi S, Suzuki R, Nakajima T, Hirai K, Nomiyama H and Yoshie O: Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 274: 27975-27980, 1999.
25. Shinkai A, Yoshisue H, Koike M, Shoji E, Nakagawa S, Saito A, Takeda T, Imabeppu S, Kato Y, Hanai N, et al: A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163: 1602-1610, 1999. (Pubitemid 29352785)
26. Daugherty BL, Siciliano SJ, De Martino JA, Malkowitz L, Sirotina A and Springer MS: Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 183: 2349-2354, 1996. (Pubitemid 26158926)
27. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, Rao P, Ponath PD, Baggiolini M and Dahinden CA: High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100: 1137-1143, 1997. (Pubitemid 27386297)
28. Gerber BO, Zanni MP, Uguccioni M, Loetscher M, Mackay CR, Pichler WJ, Yawalkar N, Baggiolini M and Moser B: Functional expression of the eotaxin receptor CCR3 in T lymphocytes colocalizing with eosinophils. Curr Biol 7: 836-843, 1997. (Pubitemid 27493122)
29. Uston PI and Lee CM: Characterization and function of the multifaceted peripheral blood basophil. Cell Mol Biol 49: 1125-1135, 2003.
30. Yssel H and Groux H: Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int Arch Allergy Immunol 121: 10-18, 2000. (Pubitemid 30079540)
31. Norman PS: Immunotherapy: 1999-2004. J Allergy Clin Immunol 113: 1013-1024, 2004.
32. De Paulis A, Montuori N, Prevete N, Fiorentino I, Rossi FW, Visconte V, Rossi G, Marone G and Ragno P: Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2. J Immunol 173: 5739-5748, 2004. (Pubitemid 39392163)
33. Nakajima H, Gleich GJ and Kita H: Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 156: 4859-4866, 1996.
34. Yousefi S, Hemmann S, Weber M, Holzer C, Hartung K, Blaser K and Simon HU: IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 154: 5481-5490, 1995.